Aimaz Afrough

15PUBLICATIONS
104CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer diagnosisPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Mar 21, 2026
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.

Cindy Varga, Myra Robinson, James A Davis

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

|Nov 03, 2025
Twin Diseases in Different Organs: A Cautionary Tale of Anchoring on a Positive Scan.

Leonard Chiu, Aimaz Afrough, Urooba Nadeem

|Oct 11, 2025
Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response.

Rahul Banerjee, Gurbakhash Kaur, Beatrice M Razzo

Pageof 3

Frequent Collaborators

12 joint publications

Doris K Hansen

12 joint publications

Surbhi Sidana

12 joint publications

Larry D Anderson

10 joint publications

Krina Patel